_id
691097f9ccc777a4e85d5be9
Ticker
EQ
Name
Equillium Inc
Exchange
NASDAQ
Address
2223 Avenida De La Playa, La Jolla, CA, United States, 92037
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.equilliumbio.com
Description
Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need in the United States. Its lead product candidate is Itolizumab (EQ001), a first-in-class anti-CD6 immune-modifying monoclonal antibody, which is in phase 3 clinical trial to treat acute graft-versus-host disease, as well as completed Phase 1b clinical trial to treat systemic lupus erythematosus and lupus nephritis and in phase 2 clinical trial for the treatment of ulcerative colitis. The company also develops EQ101, first-in-class, selective, tri-specific inhibitor of IL-2, IL-9 and IL-15, which completed Phase 1/2 to treat cutaneous T cell lymphoma. It serves its products to gastroenterology, dermatology, hematology, transplant science, rheumatology, pulmonology, and oncology areas. The company has a collaboration and license agreement with Biocon SA to develop, make, have made, use, sell, have sold, offer for sale, import and otherwise exploit itolizumab (EQ001) and any pharmaceutical composition or preparation containing or comprising itolizumab (EQ001) that uses Biocon technology or Biocon know-how, or collectively, a Biocon Product. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.
Last Close
1.34
Volume
287725
Current Price
1.28
Change
-4.4776119402985115
Last Updated
2025-11-30T18:19:26.637Z
Image
-
Ipo Date
2018-10-11T00:00:00.000Z
Market Cap
54950100
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9335
Sentiment Sources
2
Rating
3
Target Price
2.5
Strong Buy
0
Buy
0
Hold
2
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
28000
Gross Profit
-28000
Operating Expenses
4547000
Operating Income
-4575000
Interest Expense
-
Pretax Income
-4230000
Net Income
-4230000
Eps
-0.11842331699679476
Dividends Per Share
-
Shares Outstanding
60893283
Income Tax Expense
-
EBITDA
-4202000
Operating Margin
-
Total Other Income Expense Net
345000
Cash
33120000
Short Term Investments
0
Receivables
-
Inventories
-
Total Current Assets
33579000
Property Plant Equipment
927000
Total Assets
34506000
Payables
1082000
Short Term Debt
272000
Long Term Debt
-
Total Liabilities
3567000
Equity
30939000
Depreciation
28000
Change In Working Capital
-4518000
Cash From Operations
-8431000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
30069000
Net Change In Cash
21624999
PE
-
PB
1.4777699912731503
ROE
-13.672064384757102
ROA
-12.258737610850288
FCF
-8431000
Fcf Percent
-
Piotroski FScore
0
Health Score
42
Deep Value Investing Score
6
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
3.5
Quality Investing Score
3
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
28000
Quarters > 0 > income Statement > gross Profit
-28000
Quarters > 0 > income Statement > operating Expenses
4547000
Quarters > 0 > income Statement > operating Income
-4575000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-4230000
Quarters > 0 > income Statement > net Income
-4230000
Quarters > 0 > income Statement > eps
-0.11842331699679476
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
35719317
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-4202000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
345000
Quarters > 0 > balance Sheet > cash
33120000
Quarters > 0 > balance Sheet > short Term Investments
0
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
33579000
Quarters > 0 > balance Sheet > property Plant Equipment
927000
Quarters > 0 > balance Sheet > total Assets
34506000
Quarters > 0 > balance Sheet > payables
1082000
Quarters > 0 > balance Sheet > short Term Debt
272000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
3567000
Quarters > 0 > balance Sheet > equity
30939000
Quarters > 0 > cash Flow > net Income
-4230000
Quarters > 0 > cash Flow > depreciation
28000
Quarters > 0 > cash Flow > change In Working Capital
-4518000
Quarters > 0 > cash Flow > cash From Operations
-8431000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
30069000
Quarters > 0 > cash Flow > net Change In Cash
21624999
Quarters > 0 > ratios > PE
-0.11842331699679476
Quarters > 0 > ratios > PB
1.4777699912731503
Quarters > 0 > ratios > ROE
-13.672064384757102
Quarters > 0 > ratios > ROA
-12.258737610850288
Quarters > 0 > ratios > FCF
-8431000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
32000
Quarters > 1 > income Statement > gross Profit
-32000
Quarters > 1 > income Statement > operating Expenses
6196000
Quarters > 1 > income Statement > operating Income
-6228000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-5739000
Quarters > 1 > income Statement > net Income
-5739000
Quarters > 1 > income Statement > eps
-0.16066936554245984
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
35719317
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-6196000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
489000
Quarters > 1 > balance Sheet > cash
11495000
Quarters > 1 > balance Sheet > short Term Investments
0
Quarters > 1 > balance Sheet > receivables
35000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
11952000
Quarters > 1 > balance Sheet > property Plant Equipment
447000
Quarters > 1 > balance Sheet > total Assets
12399000
Quarters > 1 > balance Sheet > payables
4812000
Quarters > 1 > balance Sheet > short Term Debt
150000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
7343000
Quarters > 1 > balance Sheet > equity
5056000
Quarters > 1 > cash Flow > net Income
-5739000
Quarters > 1 > cash Flow > depreciation
32000
Quarters > 1 > cash Flow > change In Working Capital
2501000
Quarters > 1 > cash Flow > cash From Operations
-3013000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-16000
Quarters > 1 > cash Flow > net Change In Cash
-3007000
Quarters > 1 > ratios > PE
-0.16066936554245984
Quarters > 1 > ratios > PB
9.04286506329114
Quarters > 1 > ratios > ROE
-113.50870253164558
Quarters > 1 > ratios > ROA
-46.285990805710135
Quarters > 1 > ratios > FCF
-3013000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
25
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
33000
Quarters > 2 > income Statement > gross Profit
-33000
Quarters > 2 > income Statement > operating Expenses
8870000
Quarters > 2 > income Statement > operating Income
-8870000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-8654000
Quarters > 2 > income Statement > net Income
-8654000
Quarters > 2 > income Statement > eps
-0.2431796386874358
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
35586861
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-8837000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
216000
Quarters > 2 > balance Sheet > cash
14502000
Quarters > 2 > balance Sheet > short Term Investments
0
Quarters > 2 > balance Sheet > receivables
1045000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
16216000
Quarters > 2 > balance Sheet > property Plant Equipment
513000
Quarters > 2 > balance Sheet > total Assets
16729000
Quarters > 2 > balance Sheet > payables
3058000
Quarters > 2 > balance Sheet > short Term Debt
146000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
6151000
Quarters > 2 > balance Sheet > equity
10578000
Quarters > 2 > cash Flow > net Income
-8654000
Quarters > 2 > cash Flow > depreciation
33000
Quarters > 2 > cash Flow > change In Working Capital
-106000
Quarters > 2 > cash Flow > cash From Operations
-8169000
Quarters > 2 > cash Flow > capital Expenditures
4000
Quarters > 2 > cash Flow > cash From Investing
4496000
Quarters > 2 > cash Flow > cash From Financing
91000
Quarters > 2 > cash Flow > net Change In Cash
-3583000
Quarters > 2 > ratios > PE
-0.2431796386874358
Quarters > 2 > ratios > PB
4.306218763471356
Quarters > 2 > ratios > ROE
-81.81130648515787
Quarters > 2 > ratios > ROA
-51.73052782593102
Quarters > 2 > ratios > FCF
-8173000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
4392000
Quarters > 3 > income Statement > cost Of Revenue
35000
Quarters > 3 > income Statement > gross Profit
4392000
Quarters > 3 > income Statement > operating Expenses
9090000
Quarters > 3 > income Statement > operating Income
-4698000
Quarters > 3 > income Statement > interest Expense
0
Quarters > 3 > income Statement > pretax Income
-5433000
Quarters > 3 > income Statement > net Income
-5794000
Quarters > 3 > income Statement > eps
-0.16386839834705036
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
35357641
Quarters > 3 > income Statement > income Tax Expense
361000
Quarters > 3 > income Statement > EBITDA
-5398000
Quarters > 3 > income Statement > operating Margin
-106.9672131147541
Quarters > 3 > income Statement > total Other Income Expense Net
-735000
Quarters > 3 > balance Sheet > cash
18085000
Quarters > 3 > balance Sheet > short Term Investments
4490000
Quarters > 3 > balance Sheet > receivables
1144000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
24978000
Quarters > 3 > balance Sheet > property Plant Equipment
626000
Quarters > 3 > balance Sheet > total Assets
25604000
Quarters > 3 > balance Sheet > payables
2676000
Quarters > 3 > balance Sheet > short Term Debt
197000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
6543000
Quarters > 3 > balance Sheet > equity
19061000
Quarters > 3 > cash Flow > net Income
-5794000
Quarters > 3 > cash Flow > depreciation
35000
Quarters > 3 > cash Flow > change In Working Capital
2798000
Quarters > 3 > cash Flow > cash From Operations
-3299000
Quarters > 3 > cash Flow > capital Expenditures
4000
Quarters > 3 > cash Flow > cash From Investing
5996000
Quarters > 3 > cash Flow > cash From Financing
73000
Quarters > 3 > cash Flow > net Change In Cash
2637000
Quarters > 3 > ratios > PE
-0.16386839834705036
Quarters > 3 > ratios > PB
2.374365483447878
Quarters > 3 > ratios > ROE
-30.397146004931535
Quarters > 3 > ratios > ROA
-22.62927667551945
Quarters > 3 > ratios > FCF
-3303000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.7520491803278688
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
41095000
Annuals > 0 > income Statement > cost Of Revenue
137000
Annuals > 0 > income Statement > gross Profit
41095000
Annuals > 0 > income Statement > operating Expenses
49364000
Annuals > 0 > income Statement > operating Income
-8269000
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-7706000
Annuals > 0 > income Statement > net Income
-8067000
Annuals > 0 > income Statement > eps
-0.22815436131612965
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
35357641
Annuals > 0 > income Statement > income Tax Expense
361000
Annuals > 0 > income Statement > EBITDA
-7569000
Annuals > 0 > income Statement > operating Margin
-20.121669302834892
Annuals > 0 > income Statement > total Other Income Expense Net
563000
Annuals > 0 > balance Sheet > cash
18085000
Annuals > 0 > balance Sheet > short Term Investments
4490000
Annuals > 0 > balance Sheet > receivables
1144000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
24978000
Annuals > 0 > balance Sheet > property Plant Equipment
626000
Annuals > 0 > balance Sheet > total Assets
25604000
Annuals > 0 > balance Sheet > payables
2676000
Annuals > 0 > balance Sheet > short Term Debt
197000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
6543000
Annuals > 0 > balance Sheet > equity
19061000
Annuals > 0 > cash Flow > net Income
-8067000
Annuals > 0 > cash Flow > depreciation
137000
Annuals > 0 > cash Flow > change In Working Capital
842000
Annuals > 0 > cash Flow > cash From Operations
-19026000
Annuals > 0 > cash Flow > capital Expenditures
85000
Annuals > 0 > cash Flow > cash From Investing
13814000
Annuals > 0 > cash Flow > cash From Financing
164000
Annuals > 0 > cash Flow > net Change In Cash
-5131000
Annuals > 0 > ratios > PE
-0.22815436131612965
Annuals > 0 > ratios > PB
1.6739276658307538
Annuals > 0 > ratios > ROE
-42.32201878180578
Annuals > 0 > ratios > ROA
-31.50679581315419
Annuals > 0 > ratios > FCF
-19111000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.46504440929553476
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
36084000
Annuals > 1 > income Statement > cost Of Revenue
126000
Annuals > 1 > income Statement > gross Profit
36084000
Annuals > 1 > income Statement > operating Expenses
50606000
Annuals > 1 > income Statement > operating Income
-14522000
Annuals > 1 > income Statement > interest Expense
491000
Annuals > 1 > income Statement > pretax Income
-12755000
Annuals > 1 > income Statement > net Income
-13335000
Annuals > 1 > income Statement > eps
-0.38400197383061824
Annuals > 1 > income Statement > dividends Per Share
9133000
Annuals > 1 > income Statement > shares Outstanding
34726384
Annuals > 1 > income Statement > income Tax Expense
580000
Annuals > 1 > income Statement > EBITDA
-12138000
Annuals > 1 > income Statement > operating Margin
-40.24498392639397
Annuals > 1 > income Statement > total Other Income Expense Net
1767000
Annuals > 1 > balance Sheet > cash
23216000
Annuals > 1 > balance Sheet > short Term Investments
17650000
Annuals > 1 > balance Sheet > receivables
6286000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
49349000
Annuals > 1 > balance Sheet > property Plant Equipment
1111000
Annuals > 1 > balance Sheet > total Assets
50530000
Annuals > 1 > balance Sheet > payables
4707000
Annuals > 1 > balance Sheet > short Term Debt
440000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
27957000
Annuals > 1 > balance Sheet > equity
22573000
Annuals > 1 > cash Flow > net Income
-13335000
Annuals > 1 > cash Flow > depreciation
126000
Annuals > 1 > cash Flow > change In Working Capital
-2546000
Annuals > 1 > cash Flow > cash From Operations
-21783000
Annuals > 1 > cash Flow > capital Expenditures
50000
Annuals > 1 > cash Flow > cash From Investing
-4762000
Annuals > 1 > cash Flow > cash From Financing
-9228000
Annuals > 1 > cash Flow > net Change In Cash
-35891000
Annuals > 1 > ratios > PE
-0.38400197383061824
Annuals > 1 > ratios > PB
1.3882553901386614
Annuals > 1 > ratios > ROE
-59.075001107517835
Annuals > 1 > ratios > ROA
-26.390263209974275
Annuals > 1 > ratios > FCF
-21833000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.6050604145881832
Annuals > 1 > health Score
25
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
15759000
Annuals > 2 > income Statement > cost Of Revenue
118000
Annuals > 2 > income Statement > gross Profit
15759000
Annuals > 2 > income Statement > operating Expenses
77835000
Annuals > 2 > income Statement > operating Income
-62076000
Annuals > 2 > income Statement > interest Expense
1053000
Annuals > 2 > income Statement > pretax Income
-62428000
Annuals > 2 > income Statement > net Income
-62428000
Annuals > 2 > income Statement > eps
-1.8509280657330294
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
33727945
Annuals > 2 > income Statement > income Tax Expense
45279000
Annuals > 2 > income Statement > EBITDA
-61257000
Annuals > 2 > income Statement > operating Margin
-393.90824290881403
Annuals > 2 > income Statement > total Other Income Expense Net
-352000
Annuals > 2 > balance Sheet > cash
59107000
Annuals > 2 > balance Sheet > short Term Investments
11916000
Annuals > 2 > balance Sheet > receivables
4113000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
76735000
Annuals > 2 > balance Sheet > property Plant Equipment
1582000
Annuals > 2 > balance Sheet > total Assets
78421000
Annuals > 2 > balance Sheet > payables
3977000
Annuals > 2 > balance Sheet > short Term Debt
6122000
Annuals > 2 > balance Sheet > long Term Debt
3239000
Annuals > 2 > balance Sheet > total Liabilities
46479000
Annuals > 2 > balance Sheet > equity
31942000
Annuals > 2 > cash Flow > net Income
-62428000
Annuals > 2 > cash Flow > depreciation
118000
Annuals > 2 > cash Flow > change In Working Capital
19000
Annuals > 2 > cash Flow > cash From Operations
-8733000
Annuals > 2 > cash Flow > capital Expenditures
279000
Annuals > 2 > cash Flow > cash From Investing
18684000
Annuals > 2 > cash Flow > cash From Financing
-1215000
Annuals > 2 > cash Flow > net Change In Cash
8741000
Annuals > 2 > ratios > PE
-1.8509280657330294
Annuals > 2 > ratios > PB
0.9528550988666958
Annuals > 2 > ratios > ROE
-195.4417381503976
Annuals > 2 > ratios > ROA
-79.6062279236429
Annuals > 2 > ratios > FCF
-9012000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-0.5718636969350848
Annuals > 2 > health Score
24
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
72000
Annuals > 3 > income Statement > gross Profit
-72000
Annuals > 3 > income Statement > operating Expenses
37786000
Annuals > 3 > income Statement > operating Income
-37786000
Annuals > 3 > income Statement > interest Expense
1073000
Annuals > 3 > income Statement > pretax Income
-39052000
Annuals > 3 > income Statement > net Income
-38980000
Annuals > 3 > income Statement > eps
-1.3531757451752757
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
28806310
Annuals > 3 > income Statement > income Tax Expense
-72000
Annuals > 3 > income Statement > EBITDA
-37714000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-1266000
Annuals > 3 > balance Sheet > cash
50366000
Annuals > 3 > balance Sheet > short Term Investments
30345000
Annuals > 3 > balance Sheet > receivables
0
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
83760000
Annuals > 3 > balance Sheet > property Plant Equipment
1645000
Annuals > 3 > balance Sheet > total Assets
85405000
Annuals > 3 > balance Sheet > payables
1225000
Annuals > 3 > balance Sheet > short Term Debt
1804000
Annuals > 3 > balance Sheet > long Term Debt
8750000
Annuals > 3 > balance Sheet > total Liabilities
18900000
Annuals > 3 > balance Sheet > equity
66505000
Annuals > 3 > cash Flow > net Income
-39052000
Annuals > 3 > cash Flow > depreciation
72000
Annuals > 3 > cash Flow > change In Working Capital
1698000
Annuals > 3 > cash Flow > cash From Operations
-32081000
Annuals > 3 > cash Flow > capital Expenditures
57000
Annuals > 3 > cash Flow > cash From Investing
27406000
Annuals > 3 > cash Flow > cash From Financing
31061000
Annuals > 3 > cash Flow > net Change In Cash
26384000
Annuals > 3 > ratios > PE
-1.3531757451752757
Annuals > 3 > ratios > PB
0.3908700720848057
Annuals > 3 > ratios > ROE
-58.61213442598301
Annuals > 3 > ratios > ROA
-45.641355892512145
Annuals > 3 > ratios > FCF
-32138000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.11842331699679476
Valuation > metrics > PB
1.4777699912731503
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-13.672064384757102
Profitability > metrics > ROA
-12.597158938622352
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.1152913798118879
Risk > metrics > Interest Coverage
-163.39285714285714
Risk > final Score
-594
Risk > verdict
High
Liquidity > metrics > Current Ratio
24.799852289512554
Liquidity > metrics > Quick Ratio
24.799852289512554
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
36.93781236528644
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-25
Prev Risks > 1
-146
Prev Risks > 2
-477
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:26:21.685Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-18
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.06
Earnings History > 0 > eps Estimate
-0.22
Earnings History > 0 > eps Difference
0.16
Earnings History > 0 > surprise Percent
72.7273
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-06
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.16
Earnings History > 1 > eps Estimate
-0.185
Earnings History > 1 > eps Difference
0.025
Earnings History > 1 > surprise Percent
13.5135
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-22
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.24
Earnings History > 2 > eps Estimate
-0.335
Earnings History > 2 > eps Difference
0.095
Earnings History > 2 > surprise Percent
28.3582
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-27
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.16
Earnings History > 3 > eps Estimate
-0.31
Earnings History > 3 > eps Difference
0.15
Earnings History > 3 > surprise Percent
48.3871
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-13
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.0002
Earnings History > 4 > eps Estimate
0.0175
Earnings History > 4 > eps Difference
-0.0177
Earnings History > 4 > surprise Percent
-101.1429
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
0.01
Earnings History > 5 > eps Estimate
-0.15
Earnings History > 5 > eps Difference
0.16
Earnings History > 5 > surprise Percent
106.6667
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.08
Earnings History > 6 > eps Estimate
-0.15
Earnings History > 6 > eps Difference
0.07
Earnings History > 6 > surprise Percent
46.6667
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-25
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.07
Earnings History > 7 > eps Estimate
-0.17
Earnings History > 7 > eps Difference
0.1
Earnings History > 7 > surprise Percent
58.8235
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-08
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.11
Earnings History > 8 > eps Estimate
-0.17
Earnings History > 8 > eps Difference
0.06
Earnings History > 8 > surprise Percent
35.2941
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-09
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.1
Earnings History > 9 > eps Estimate
-0.17
Earnings History > 9 > eps Difference
0.07
Earnings History > 9 > surprise Percent
41.1765
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.11
Earnings History > 10 > eps Estimate
-0.27
Earnings History > 10 > eps Difference
0.16
Earnings History > 10 > surprise Percent
59.2593
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-23
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.08
Earnings History > 11 > eps Estimate
-0.03
Earnings History > 11 > eps Difference
0.11
Earnings History > 11 > surprise Percent
366.6667
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.4
Earnings History > 12 > eps Estimate
-0.38
Earnings History > 12 > eps Difference
-0.02
Earnings History > 12 > surprise Percent
-5.2632
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-15
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.41
Earnings History > 13 > eps Estimate
-0.41
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
0
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-12
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.45
Earnings History > 14 > eps Estimate
-0.37
Earnings History > 14 > eps Difference
-0.08
Earnings History > 14 > surprise Percent
-21.6216
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-23
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.36
Earnings History > 15 > eps Estimate
-0.34
Earnings History > 15 > eps Difference
-0.02
Earnings History > 15 > surprise Percent
-5.8824
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.35
Earnings History > 16 > eps Estimate
-0.34
Earnings History > 16 > eps Difference
-0.01
Earnings History > 16 > surprise Percent
-2.9412
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-10
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.31
Earnings History > 17 > eps Estimate
-0.31
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
0
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-13
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.33
Earnings History > 18 > eps Estimate
-0.32
Earnings History > 18 > eps Difference
-0.01
Earnings History > 18 > surprise Percent
-3.125
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-24
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.36
Earnings History > 19 > eps Estimate
-0.4
Earnings History > 19 > eps Difference
0.04
Earnings History > 19 > surprise Percent
10
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-10
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.31
Earnings History > 20 > eps Estimate
-0.4
Earnings History > 20 > eps Difference
0.09
Earnings History > 20 > surprise Percent
22.5
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-12
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.37
Earnings History > 21 > eps Estimate
-0.45
Earnings History > 21 > eps Difference
0.08
Earnings History > 21 > surprise Percent
17.7778
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-13
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.45
Earnings History > 22 > eps Estimate
-0.42
Earnings History > 22 > eps Difference
-0.03
Earnings History > 22 > surprise Percent
-7.1429
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-26
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.44
Earnings History > 23 > eps Estimate
-0.39
Earnings History > 23 > eps Difference
-0.05
Earnings History > 23 > surprise Percent
-12.8205
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-12
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.35
Earnings History > 24 > eps Estimate
-0.4
Earnings History > 24 > eps Difference
0.05
Earnings History > 24 > surprise Percent
12.5
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-12
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.35
Earnings History > 25 > eps Estimate
-0.34
Earnings History > 25 > eps Difference
-0.01
Earnings History > 25 > surprise Percent
-2.9412
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-13
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.34
Earnings History > 26 > eps Estimate
-0.3
Earnings History > 26 > eps Difference
-0.04
Earnings History > 26 > surprise Percent
-13.3333
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-03-27
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
AfterMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.31
Earnings History > 27 > eps Estimate
-0.29
Earnings History > 27 > eps Difference
-0.02
Earnings History > 27 > surprise Percent
-6.8966
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-11-15
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
AfterMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.44
Earnings History > 28 > eps Estimate
-0.11
Earnings History > 28 > eps Difference
-0.33
Earnings History > 28 > surprise Percent
-300
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-08-03
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.06
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
-0.06
Earnings History > 29 > surprise Percent
-
Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need in the United States. Its lead product candidate is Itolizumab (EQ001), a first-in-class anti-CD6 immune-modifying monoclonal antibody, which is in phase 3 clinical trial to treat acute graft-versus-host disease, as well as completed Phase 1b clinical trial to treat systemic lupus erythematosus and lupus nephritis and in phase 2 clinical trial for the treatment of ulcerative colitis. The company also develops EQ101, first-in-class, selective, tri-specific inhibitor of IL-2, IL-9 and IL-15, which completed Phase 1/2 to treat cutaneous T cell lymphoma. It serves its products to gastroenterology, dermatology, hematology, transplant science, rheumatology, pulmonology, and oncology areas. The company has a collaboration and license agreement with Biocon SA to develop, make, have made, use, sell, have sold, offer for sale, import and otherwise exploit itolizumab (EQ001) and any pharmaceutical composition or preparation containing or comprising itolizumab (EQ001) that uses Biocon technology or Biocon know-how, or collectively, a Biocon Product. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AInsider Sale: Sr. Vice President and COO of $EQ Sells 11,900 Shares Quiver Quantitative
Read more →Chip Stocks Meet Harvard’s Criteria for a Bubble: Equity Insight Bloomberg.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$2.5
Analyst Picks
Strong Buy
0
Buy
0
Hold
2
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 16.87% of the total shares of Equillium Inc
1.
Decheng Capital LLC(7.4741%)
since
2025/06/30
2.
Takeda Pharmaceutical Co Ltd(3.067%)
since
2025/06/30
3.
Vanguard Group Inc(1.385%)
since
2025/06/30
4.
Cota Capital Management, LLC(0.945%)
since
2025/06/30
5.
Vanguard Total Stock Mkt Idx Inv(0.9388%)
since
2025/07/31
6.
Renaissance Technologies Corp(0.4606%)
since
2025/06/30
7.
abrdn Life Sciences Investors(0.3801%)
since
2025/08/31
8.
Geode Capital Management, LLC(0.3295%)
since
2025/06/30
9.
Vanguard Institutional Extnd Mkt Idx Tr(0.2857%)
since
2025/07/31
10.
Citadel Advisors Llc(0.2197%)
since
2025/06/30
11.
Callan Capital, LLC(0.1675%)
since
2025/03/31
12.
Fidelity Extended Market Index(0.1666%)
since
2025/07/31
13.
UBS Group AG(0.1404%)
since
2025/06/30
14.
State Street Corp(0.1004%)
since
2025/06/30
15.
AlphaCore Capital LLC(0.088%)
since
2025/06/30
16.
Prudential Financial Inc(0.0659%)
since
2025/06/30
17.
PGIM Quantitative Solutions US Micro Cap(0.0659%)
since
2025/06/30
18.
Fidelity Total Market Index(0.0592%)
since
2025/07/31
19.
Northern Trust Corp(0.0589%)
since
2025/06/30
20.
Commonwealth Equity Services Inc(0.042%)
since
2025/06/30
21.
Fidelity Series Total Market Index(0.0413%)
since
2025/07/31
22.
Baader Bank INC(0.0398%)
since
2025/06/30
23.
Spartan Extended Market Index Pool F(0.0313%)
since
2025/07/31
24.
Vanguard Instl Ttl Stck Mkt Idx Tr(0.03%)
since
2024/12/31
25.
NT Ext Equity Mkt Idx Fd - NL(0.0284%)
since
2025/06/30
26.
Ground Swell Capital, LLC(0.0278%)
since
2025/06/30
27.
NT Ext Equity Mkt Idx Fd - L(0.0275%)
since
2025/06/30
28.
Northern Trust Extended Eq Market Idx(0.0275%)
since
2025/06/30
29.
Susquehanna International Group, LLP(0.0254%)
since
2025/06/30
30.
Apollon Wealth Management, LLC(0.0233%)
since
2025/06/30
31.
TRITONPOINT WEALTH LLC(0.0227%)
since
2025/06/30
32.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.022%)
since
2025/06/30
33.
Virtu Financial LLC(0.0171%)
since
2025/06/30
34.
Fidelity Nasdaq Composite Index(0.0158%)
since
2025/07/31
35.
Spartan Total Market Index Pool G(0.0152%)
since
2025/07/31
36.
Vanguard U.S. Eq Idx £ Acc(0.0098%)
since
2025/07/31
37.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0078%)
since
2025/06/30
38.
State St US Extended Mkt Indx NL Cl C(0.0069%)
since
2025/08/31
39.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0066%)
since
2024/12/31
40.
State St US Ttl Mkt Indx NL Cl A(0.0035%)
since
2025/08/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.06
EPS Estimate
-0.22
EPS Difference
0.16
Surprise Percent
72.7273%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.